Skip to main content

Schwangerschaftsabbruch

  • Chapter
Die Geburtshilfe
  • 1699 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alan Guttmacher Institute (1996) Facts in brief: induced abortion. The Alan Guttmacher Institute, New York

    Google Scholar 

  • Ashok PW, Penney GC, Flett GM et al. (1998) An effective regimen for early abortion: a report of 2000 consecutive cases. Hum Reprod 13:2962–2965

    PubMed  CAS  Google Scholar 

  • Beaulieu EE, Segal SJ (eds) (1985) The antiprogesterone steroid RU 486 and human fertility control. Plenum, New York

    Google Scholar 

  • Beller FK (1996) Wie klein ist zu klein, wie groĂź ist zu groĂź? Frauenarzt 37: 929–933

    Google Scholar 

  • Beller FK, DeProsse CHA (1992) The confusion of trimester and viability and the consequences for the abortion law. J Reprod Med 37: 537–540

    PubMed  CAS  Google Scholar 

  • Carbonell JLI, Varela L, Velazco A et al. (1999) Early abortion with 800 µg of misopristol by the vaginal route. Contraception 59:219–225

    Article  Google Scholar 

  • CDC (1980) Abortion surveillance 1978. Centers for Disease Control, Atlanta/GA

    Google Scholar 

  • Creinin MD, Darney PD (1993) Methotrexate and misoprostol for early abortion. Contraception 48:339–342

    Article  PubMed  CAS  Google Scholar 

  • Creinin MD, Pymar HC (2001) Mifepristone 100 mg in abortion regimens. Obstet Gynecol 98:434–439

    Article  PubMed  CAS  Google Scholar 

  • Creinin MD, Vittinghoff E, Keder L et al. (1996) Methotrexate and misoprostol for early abortion: A multicenter trial. I Safety and efficacy. Contraception 53:321–327

    Article  PubMed  CAS  Google Scholar 

  • Cuttini M, Nadei M, Kaminski M et al. (2000) End-of-life decisions in neonatal care: physicians self-reported practice in seven European countries. Lancet 355:2112–2118

    Article  PubMed  CAS  Google Scholar 

  • Darney TD, Sweet RL (1989) Routine intraoperative ultrasound for second trimester abortion reduces incidence of uterine perforation. J Ultrasound Med 8:71–75

    PubMed  CAS  Google Scholar 

  • DGGG (2002) Positionenpapier»Pränataldiagnostik — Beratung und möglicher Schwangerschaftsabbruch«

    Google Scholar 

  • Elam-Evans DE, Strauss LT, Herndon J et al. (2003) Abortion surveillance — United States, 2000. MMWR CDC Surveill Summ 52(SS-12): 1–32

    Google Scholar 

  • El-Rafey H, Rasekar D, Abdalla M (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332:983–987

    Article  Google Scholar 

  • Fathalla MF (1997) Gesellschaft und menschliche Reproduktion. Festrede FIGO-Kongress Kopenhagen, Okt. 1997

    Google Scholar 

  • Grimes DA (1984) Second trimester abortion in the United States. Fam Plann Perspect 16:260–265

    Article  PubMed  CAS  Google Scholar 

  • Grimes DA, Cook RJ (1992) Mifepristone (RU 486), an abortificiant to prevent abortion. N Engl J Med 327:1088–1089

    Article  PubMed  CAS  Google Scholar 

  • Grimes DA, Schulz KF, Cates W Jr (1984) Prophylactic antibiotics for curettage. Am J Obstet Gynecol 150:689

    PubMed  CAS  Google Scholar 

  • Grimes DA, Stubblefield PG (1999) A clinician guide to medical and surgical abortion. Churchill Livingstone, New York, pp 192–216

    Google Scholar 

  • Grou F, Rodrigues I (1994) The morning-after pill — how long after? Am J Obstet Gynecol 171:1529–1534

    PubMed  CAS  Google Scholar 

  • Goldberg AB, Greenberg MB, Darney PD (2001) Drug therapy: misopristol and pregnancy. N Engl J Med 334:38–47

    Article  Google Scholar 

  • Halperin R. Vaknin Z, Langer R et al. (2003) Late midtrimester pregnancy termination in the presence of placenta praevia. J Reprod Med 48: 175–178

    PubMed  Google Scholar 

  • Hakim-Elahi E, Tovell HM, Burnhil MS (1990) Complications of first-trimester abortion: a report of 170.000 cases. Obstet Gynecol 76:129–135

    PubMed  CAS  Google Scholar 

  • Hausknecht RU (1995) Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 333:537–540

    Article  PubMed  CAS  Google Scholar 

  • Hausknecht R (2003) Mifepristone and misopristol for early medical abortion: 18 months experience in the United States. Contraception 67: 463–465

    Article  PubMed  CAS  Google Scholar 

  • Henshaw SK, Morrow E (1990) Induced abortion, a world review. Fam Plann Perspect 22:76–120

    Article  PubMed  CAS  Google Scholar 

  • Hepp H (1996) Pränatalmedizin und reformierter § 218a StGB — oder: die versteckte Indikation. Gynäkologe 29:407–411

    Google Scholar 

  • Jain JK, Meckstroh M, Park M (2000) A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination. Am J Obstet Gynecol 60:353–356

    Google Scholar 

  • Johnson TRB, Harris LH, Dalton VK et al. (2005) Language matters: legislation, medical practice, and the classification of abortion procedures. Obstet Gynecol 105:201–204

    PubMed  Google Scholar 

  • Lindblom B (1992) Ectopic pregnancy — laparoscopic and medical treatment. Curr Opin Obstet Gynecol 4:400–405

    PubMed  CAS  Google Scholar 

  • Lippes J, Malik T, Tatum HJ (1976) The post coital copper T. Adv Plann Parenthood 11:24

    CAS  Google Scholar 

  • Mac Isaac L, Creinin MD (2000) Early surgical abortion an alternative and backup for medical abortion. Am J Obstet Gynecol 183:76–83

    Article  Google Scholar 

  • Mac Isaac L, Grossman B, Baliestreri E, Darney PA (1999) A randomized controlled trial of laminaria, oral misoprostol and vaginal misoprostol before abortion. Obstet Gynecol 93:766–770

    Article  CAS  Google Scholar 

  • McCullogh LB, Chervenak FA (1994) Ethics in obstetrics and gynecology. Oxford University Press

    Google Scholar 

  • Mund M (2001) Der medikamentöse Schwangerschaftsabbruch mit Mifepriston. Frauenarzt 42:952

    Google Scholar 

  • Paul M, Lackie E, Mitchell C et al. (2002) Is pathology examination useful after early surgical abortion. Obstet Gynecol 99:567–571

    Article  PubMed  Google Scholar 

  • Peyron R, Aubry E, Targosz V, Silvestre L, Renault M, Elkik F et al. (1993) Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328:1509–1513

    Article  PubMed  CAS  Google Scholar 

  • Pirruccello EP, Newhall MD, Winikoff R (2000) Abortion with mifepristone and misoprostol: Regimens acceptability and future directions. J Obstet Gynecol 183:44–53

    Article  Google Scholar 

  • Ross GT, Goldstein M, Hertz R et al. (1965) Sequential use of methotrexate and actinomycin D in the treatment of metastatic chorion carcinoma and related throphoblastic disease in women. Am J Obstet Gynecol 150:189

    Google Scholar 

  • Schaff EA, Penmeetsa U, Eisinger ST H, Franks P (1997) Methotrexate — a single agent for abortion. J Reprod Med 42:56–60

    PubMed  CAS  Google Scholar 

  • Schaff EA, Fielding SL, Westhoff C et al. (2000) Vaginal misoprostol administered 1,2 or 3 days after mifeprostone for early medical abortion: a randomized trial. JAMA 284:1984–1953

    Article  Google Scholar 

  • Schneider D, Bukowsky J, Caspi E (1994) Safety of mid trimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section. Am J Obstet Gynecol 171:554–557

    PubMed  CAS  Google Scholar 

  • Schneider D, Halparin R, Langer R, Caspi E, Bukowski I (1996) Abortion at 18–22 weeks by laminaria dilatation and evacuation. Obstet Gynecol 88:412–414

    Article  PubMed  CAS  Google Scholar 

  • SchĂĽssler B (1997) Prostaglandinanwendung in Gynäkologie und Geburtshilfe. Standard-Therapiekonzepte und neue Alternativen. Frauenheilkd Aktuell 1:4–8

    Google Scholar 

  • Schweizerische Gesellschaft fĂĽr Gynäkologie und Geburtshilfe, Kommission Qualitätssicherung (2003) Verwendung von Mifepriston fĂĽr den medikamentösen Schwangerschaftsabbruch. Expertenbrief No 5

    Google Scholar 

  • Spitz IM, Bardin CW, Benton L et al. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338:1241–1247

    Article  PubMed  CAS  Google Scholar 

  • Statistisches Bundesamt (2004) Gesundheitswesen, Fachserie 12, Reihe 3

    Google Scholar 

  • Stoval TG, Ling FW (1993) Single dose methotrexate: an expanded dilatation trail. Am J Obstet Gynecol 48:339–348

    Google Scholar 

  • Stubblefield PG, Carr-Ellis S, Borgatta L (2004) Methods for induced abortions. Obstet Gynecol 104:174–185

    PubMed  Google Scholar 

  • Task Force (1999) Postovulatory Methods for Fertility Regulation: Randomised controll trial of levonogestrel vs the Yupze regimen of combined oral contraception for emergency contraception. Lancet 352:428–433

    Google Scholar 

  • Todd CS, Soler M, Castleman M et al. (2002) Buccal misoprostol as a cervical preparation for second trimester pregnancy termination. Contraception 65:415–418

    Article  PubMed  CAS  Google Scholar 

  • Westfall JM, Sophocles A, Burggraf H et al. (1998) Manual vacuum aspiration for trimester abortion. Arch Fam Med 7:559–562

    Article  PubMed  CAS  Google Scholar 

  • WHO (1991) Pregnancy termination with mifepristone and gemeprost. A multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56:32–40

    Google Scholar 

  • Wiebe ER (1999) Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion. Am J Obst Gynecol 181: 149–152

    Article  CAS  Google Scholar 

  • Wiebe ER, Dunns G, Gilbert E et al. (2002) Comparison of abortions induced by methotrexate or Mifepristone followed by Misoprostol. Obstet Gynecol 99:813–819

    Article  PubMed  CAS  Google Scholar 

  • Winkler M, Rath W (1997) Aktuelles Vorgehen bei der vorzeitigen Schwangerschaftsbeendigung mit Prostaglandinen im II. und III. Trimenon. Z Geburtsh Neonatol 201:39–43

    CAS  Google Scholar 

  • Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM (1991) Mid second trimester labor induction, concentrated oxytocin compared with Prostaglandin E2 Supp. Obstet Gynecol 77:297–300

    Article  PubMed  CAS  Google Scholar 

  • Wood SL, Brain PH (2000) Medical management of missed abortion. A randomized clinical trial. Obstet Gynecol 99:563–566

    Article  Google Scholar 

  • Yupze A, Smith RP, Rademaker AW (1982) A multicenter clinical trial investigation employing ethinylestradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 37:508–513

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schneider, H., Beller, F.K. (2006). Schwangerschaftsabbruch. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33897-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33897-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33896-3

  • Online ISBN: 978-3-540-33897-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics